CD34 and Cirrhosis: Moreover, four of the eight patients (50%) in the CD34+ cell group exhibited an improvement from decompensated to compensated cirrhosis, while all patients in the SOC group remained in the decompensated stage of cirrhosis (Fig. S5C).